GO:0006518 peptide metabolic process: Peptide Metabolism Pathway, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0006518 peptide metabolic process describes all chemical reactions and pathways involving peptides, which are compounds of two or more amino acids linked by peptide bonds.
• Peptides are central to cellular signaling, immune recognition, and metabolic control, and their metabolism is tightly regulated in health and disease.
• Key genes in peptide metabolic processes include enzymes for peptide bond formation and cleavage, peptide transporters, and peptide-modifying enzymes such as those involved in acylation.
• Dysregulation of peptide metabolic processes is linked to neurological disorders, metabolic diseases, and cancer, making these pathways important therapeutic targets.
• CRISPR-based models, including knockout, point mutation, knock-in, and overexpression, enable precise dissection of peptide metabolic gene function.
• Advanced methods such as Ribo-seq, proteomics, and peptide macrocyclization strategies are essential for studying peptide metabolism and developing peptide-based therapeutics.
Description
Peptide metabolic process (GO:0006518) encompasses the chemical reactions and pathways involving peptides, which are short chains of amino acids linked by peptide bonds. Peptides serve diverse biological roles, from neurotransmitters and hormones to antimicrobial agents and immune modulators, and their metabolism is fundamental to cellular homeostasis. Understanding peptide metabolic processes is critical for researchers in biochemistry, cell biology, and drug discovery, as these pathways influence signal transduction, protein turnover, and metabolic regulation. Recent advances in peptide chemistry and biology have highlighted the importance of peptide macrocyclization, self-assembly, and targeted delivery in both natural and synthetic systems. Moreover, peptides are key players in disease mechanisms, including cerebral ischemia-reperfusion injury and neoantigen recognition in cancer immunotherapy. This article provides a comprehensive overview of GO:0006518, covering its definition, biological significance, key genes, regulatory mechanisms, disease associations, and cutting-edge research methods, with a focus on how CRISPR-based models can accelerate discovery in this field.
peptide metabolic process At A Glance
| GO ID | GO:0006518 |
|---|---|
| GO term | peptide metabolic process |
| Ontology | biological_process |
| Synonym | peptide metabolism |
| Definition | The chemical reactions and pathways involving peptides, compounds of two or more amino acids where the alpha carboxyl group of one is bound to the alpha amino group of another. |
| Major function | Encompasses synthesis, modification, cleavage, and degradation of peptides involved in signaling, immunity, and metabolism. |
| Related processes | Proteolysis, peptide hormone processing, protein turnover, and peptide transport. |
| Key enzymes | Peptidases, peptide synthases, and peptide-modifying enzymes such as acyltransferases. |
| Disease relevance | Neurological disorders, metabolic diseases, cancer, and immune disorders. |
What Is GO:0006518?
According to the Gene Ontology, peptide metabolic process (GO:0006518) is defined as the chemical reactions and pathways involving peptides, compounds of two or more amino acids where the alpha carboxyl group of one is bound to the alpha amino group of another. This term captures all enzymatic and non-enzymatic transformations of peptides, including their synthesis, modification, cleavage, and degradation. It is a broad biological process that intersects with proteolysis, peptide hormone processing, and the metabolism of signaling peptides.
Why Is peptide metabolic process Important in Cell Biology?
Peptide metabolic process is fundamental to life because peptides act as signaling molecules, hormones, neurotransmitters, and immune effectors, and their metabolism determines the duration and intensity of these signals. Dysregulation of peptide metabolism contributes to a wide range of pathologies, including cerebral ischemia-reperfusion injury, metabolic disorders such as obesity and diabetes, and cancer immune evasion. Moreover, peptides are increasingly used as therapeutics, and understanding their metabolic fate is essential for drug design and delivery. Thus, GO:0006518 is a critical node for both basic research and translational applications.
• Peptides regulate key physiological processes including appetite, growth, and immune responses.
• Peptide metabolism controls the half-life and activity of hormones and neurotransmitters.
• Dysregulated peptide metabolism is implicated in neurodegeneration and cerebral ischemia.
• Peptide-MHC complexes are central to T cell recognition and neoantigen selectivity in cancer.
• Peptide-based biomaterials and peptidomimetics are emerging in regenerative medicine.
• Peptide macrocyclization strategies enhance stability and bioavailability for therapeutic use.
• Nuclear targeting of peptide nanoassemblies offers new avenues for gene editing and drug delivery.
• Understanding peptide metabolism aids in the design of peptide-based drugs with improved pharmacokinetics.
• CRISPR screening can identify genes that regulate peptide metabolic pathways.
• Peptide metabolic enzymes are potential drug targets for metabolic and neurological diseases.
What Happens During peptide metabolic process?
Peptide Biosynthesis and Processing
In simple terms: Cells build peptides by linking amino acids together and then trimming them to their active forms.
Peptide biosynthesis involves the formation of peptide bonds between amino acids, often as part of larger precursor proteins that are subsequently cleaved by proteases to release active peptides. For example, ghrelin is synthesized as a preprohormone and undergoes acylation and cleavage to become active. This processing is essential for generating bioactive peptides that function in signaling and metabolism.
Peptide Modification
In simple terms: After being made, peptides can be chemically modified to change their properties.
Peptides undergo various post-translational modifications, including acylation, phosphorylation, and cyclization, which alter their stability, activity, and interactions. Ghrelin acylation is a classic example where the addition of an acyl group is required for its biological activity in metabolic control. Such modifications are critical for peptide function and are often dysregulated in disease.
Peptide Degradation and Turnover
In simple terms: Peptides are broken down by enzymes to terminate their signals and recycle amino acids.
Peptidases and proteases cleave peptides into smaller fragments or individual amino acids, thereby regulating the duration of peptide signaling and maintaining amino acid pools. This degradation is tightly controlled and can be influenced by cellular conditions and disease states. For instance, in cerebral ischemia-reperfusion injury, peptide degradation pathways modulate neuroinflammation.
Peptide Transport and Delivery
In simple terms: Peptides must be moved to the right place inside or outside cells to do their jobs.
Peptides can be transported across membranes or delivered to specific cellular compartments via transporters or nanocarriers. Nuclear targeting of peptide nanoassemblies is an emerging strategy for delivering peptides to the nucleus for gene regulation. This transport is essential for peptide function and is being exploited for therapeutic delivery.
Peptide Self-Assembly and Biomaterials
In simple terms: Some peptides can spontaneously assemble into larger structures with useful properties.
Peptides can self-assemble into nanostructures, hydrogels, and biomaterials that are used in regenerative medicine and drug delivery. These assemblies are governed by peptide sequence and environmental conditions, and they represent a bridge between peptide metabolism and materials science. Understanding peptide self-assembly is important for designing novel biomaterials.
Key Genes Involved in GO:0006518 peptide metabolic process
The following genes and proteins are key players in peptide metabolic processes, including peptide synthesis, modification, degradation, and transport, as supported by the literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| GHRL | Encodes ghrelin, a peptide hormone involved in appetite and metabolic control; requires acylation for activity. | Studying ghrelin acylation and its role in energy homeostasis and obesity. |
| ANXA1 | Annexin A1, a protein that can be SUMOylated and is involved in neuroinflammation; Tat-NTS peptide targets ANXA1. | Investigating peptide-based protection against cerebral ischemia-reperfusion injury. |
| HLA-A | Major histocompatibility complex class I, presents peptides to T cells; dynamic allostery in peptide/MHC complex. | Understanding TCR neoantigen selectivity for cancer immunotherapy. |
| B2M | Beta-2-microglobulin, a component of MHC class I that presents peptides to immune cells. | Studying peptide presentation and immune recognition in cancer. |
| TAP1 | Transporter associated with antigen processing, transports peptides into the ER for MHC loading. | Exploring peptide transport in immune surveillance. |
| TAP2 | Partner of TAP1 in peptide transport for antigen presentation. | Investigating defects in peptide transport in immune disorders. |
| PSMB8 | Immunoproteasome subunit that generates peptides for MHC class I presentation. | Studying peptide generation in immune responses. |
| PSMB9 | Another immunoproteasome subunit involved in peptide processing. | Research on peptide repertoire in cancer and autoimmunity. |
| LNPEP | Leucyl/cystinyl aminopeptidase, involved in peptide processing and degradation. | Exploring peptide hormone regulation in metabolic diseases. |
| CPE | Carboxypeptidase E, processes peptide hormones and neuropeptides. | Investigating peptide processing in neuroendocrine disorders. |
| PCSK1 | Proprotein convertase subtilisin/kexin type 1, cleaves prohormones to active peptides. | Studying peptide hormone maturation in obesity and diabetes. |
| PCSK2 | Proprotein convertase subtilisin/kexin type 2, involved in neuropeptide processing. | Research on neuropeptide metabolism in neurological diseases. |
| ACE | Angiotensin-converting enzyme, processes angiotensin peptides and regulates blood pressure. | Investigating peptide metabolism in cardiovascular disease. |
| DPP4 | Dipeptidyl peptidase 4, degrades incretin peptides and regulates glucose metabolism. | Studying peptide degradation in diabetes and metabolic syndrome. |
| MME | Neprilysin, a peptidase that degrades amyloid-beta and other peptides. | Research on peptide degradation in Alzheimer's disease and neuroprotection. |
| LNPEP | Leucyl/cystinyl aminopeptidase, involved in peptide processing and degradation. | Exploring peptide hormone regulation in metabolic diseases. |
| SEC11A | Signal peptidase complex subunit, involved in peptide processing in the ER. | Studying peptide maturation in secretory pathways. |
| SPCS1 | Signal peptidase complex subunit, processes signal peptides. | Research on peptide metabolism in protein secretion. |
How Is peptide metabolic process Regulated?
Peptide metabolic process is regulated at multiple levels, including transcriptional control of peptide precursors and processing enzymes, post-translational modifications such as acylation and phosphorylation, and feedback loops involving peptide hormones. For instance, ghrelin acylation is regulated by the enzyme GOAT (ghrelin O-acyltransferase), which is sensitive to nutrient availability. Additionally, peptide degradation by peptidases such as DPP4 and ACE is tightly controlled to maintain peptide homeostasis. In immune contexts, peptide loading onto MHC molecules is regulated by the peptide transporter TAP and the immunoproteasome. Dysregulation of these regulatory mechanisms can lead to disease, highlighting the importance of understanding peptide metabolic regulation.
peptide metabolic process and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| ANXA1 | Cerebral ischemia-reperfusion injury; neuroinflammation | Knockout or knock-in of SUMOylation sites in microglia |
| GHRL | Obesity and metabolic syndrome; ghrelin acylation | Point mutation of acylation site or knockout in mice |
| HLA-A | Cancer immunotherapy; neoantigen recognition | Knock-in of specific neoantigen peptides in tumor cells |
| DPP4 | Type 2 diabetes; incretin degradation | Knockout or point mutation to study inhibitor resistance |
| MME | Alzheimer's disease; amyloid-beta degradation | Overexpression or knockout in neuronal cells |
Peptide Metabolism in Neurological Disorders
Peptide metabolic processes are critically involved in neurological disorders. For example, the Tat-NTS peptide protects neurons against cerebral ischemia-reperfusion injury by modulating ANXA1 SUMOylation in microglia. This suggests that peptide-based interventions can target neuroinflammatory pathways. Additionally, peptidases such as neprilysin degrade amyloid-beta, and their dysfunction is linked to Alzheimer's disease. Thus, peptide metabolism is a promising therapeutic target for neurodegeneration.
Peptide Metabolism in Cancer and Immune Evasion
Peptide-MHC complexes are central to T cell-mediated immune surveillance, and dynamic allostery in these complexes enables TCR neoantigen selectivity. Defects in peptide processing or presentation can lead to immune evasion in cancer. Therefore, understanding peptide metabolic processes in antigen presentation is crucial for developing cancer immunotherapies.
Peptide Metabolism in Metabolic Diseases
Peptide hormones such as ghrelin regulate appetite and energy balance, and their acylation is essential for activity. Dysregulation of ghrelin acylation and other peptide processing events contributes to obesity and metabolic syndrome. Moreover, peptidases like DPP4 degrade incretin peptides, and their inhibition is a therapeutic strategy for type 2 diabetes. Thus, peptide metabolism is a key area in metabolic disease research.
From peptide metabolic process-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does gene X regulate peptide hormone processing? | Knockout of gene X in cell lines or mice |
| Does a specific point mutation in a peptide affect its stability? | Point mutation knock-in using CRISPR |
| Can a tagged peptide be tracked in live cells? | Knock-in of fluorescent tag |
| Does overexpression of a peptidase alter peptide levels? | Overexpression via lentiviral transduction |
| Which genes are essential for peptide metabolism? | CRISPR library screening |
| How does a peptide variant affect immune recognition? | Knock-in of mutant peptide in MHC-expressing cells |
How to Study the peptide metabolic process Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Ribo-seq | Translation efficiency and codon occupancy | Studying peptide precursor translation |
| RNA-seq | Transcript abundance | Gene expression profiling of peptide metabolic enzymes |
| Proteomics | Protein and peptide abundance, modifications | Identifying peptide processing intermediates |
| Peptidomics | Endogenous peptide repertoire | Discovering novel bioactive peptides |
| Live-cell imaging | Peptide localization and dynamics | Tracking peptide delivery and transport |
| CRISPR knockout screening | Gene essentiality for peptide metabolism | Identifying regulators of peptide processing |
| CRISPR activation screening | Gene overexpression effects | Enhancing peptide production |
| Peptide macrocyclization | Stability and bioactivity of cyclic peptides | Designing therapeutic peptides |
Ribo-seq and RNA-seq for Peptide Metabolism
Ribo-seq measures translation of peptide precursors and processing enzymes at codon resolution, while RNA-seq quantifies transcript levels. These methods can identify genes involved in peptide metabolism and their regulation.
Proteomics and Peptidomics
Mass spectrometry-based proteomics and peptidomics allow comprehensive identification and quantification of peptides and their modifications. This is essential for studying peptide processing and degradation.
Imaging and Fluorescent Tagging
Fluorescent tagging of peptides or their receptors enables live-cell imaging of peptide trafficking and localization. This approach is useful for studying peptide transport and delivery.
CRISPR Screening and Functional Genomics
CRISPR knockout or activation screens can systematically identify genes that regulate peptide metabolic processes. This is powerful for discovering new players in peptide metabolism and disease.
How CRISPR Can Be Used to Study GO:0006518 peptide metabolic process
Knockout
CRISPR knockout of genes involved in peptide metabolism, such as GHRL or DPP4, can reveal their roles in peptide processing and disease. For example, knocking out ANXA1 SUMOylation sites can protect neurons in ischemia models.
Point Mutation
Point mutations can be introduced to study specific amino acid residues critical for peptide function, such as the acylation site of ghrelin. This helps dissect the molecular mechanisms of peptide metabolism.
Knock-in
Knock-in of tagged peptides or mutant MHC alleles allows tracking and functional analysis of peptide presentation. This is particularly useful for studying neoantigen recognition in cancer.
Overexpression
Overexpression of peptide-processing enzymes or peptide precursors can model gain-of-function states and identify downstream effects. This approach is valuable for studying peptide hormone excess or deficiency.
How EDITGENE Supports peptide metabolic process Research
Researchers studying peptide metabolic process-related genes often need to determine whether a candidate gene is causally involved in peptide synthesis, modification, or degradation. EDITGENE provides a comprehensive suite of CRISPR services to enable precise genetic manipulation and functional interrogation of these pathways.
Contact EDITGENE today to design your custom CRISPR model for peptide metabolic process research.
Related Products
| Product name | Cat.No. | Species | Gene ID | |
|---|---|---|---|---|
| CPD Knockout HEK293 Cell Line | EDJ-KQ2097 | Human | 1362 | Details Get a Quote |
| PAM Knockout HEK293 Cell Line | EDJ-KQ3963 | Human | 5066 | Details Get a Quote |
| AEBP1 Knockout HEK293 Cell Line | EDJ-KQ4016 | Human | 165 | Details Get a Quote |
| CMA1 Knockout HEK293 Cell Line | EDJ-KQ4296 | Human | 1215 | Details Get a Quote |
| CPE Knockout HEK293 Cell Line | EDJ-KQ4329 | Human | 1363 | Details Get a Quote |
| CPN1 Knockout HEK293 Cell Line | EDJ-KQ4334 | Human | 1369 | Details Get a Quote |
| CPZ Knockout HEK293 Cell Line | EDJ-KQ6272 | Human | 8532 | Details Get a Quote |
| ABCB9 Knockout HEK293 Cell Line | EDJ-KQ7343 | Human | 23457 | Details Get a Quote |
| DNPEP Knockout HEK293 Cell Line | EDJ-KQ8060 | Human | 23549 | Details Get a Quote |
| CPM Knockout HEK293 Cell Line | EDJ-KQ12995 | Human | 1368 | Details Get a Quote |
| MME Knockout HEK293 Cell Line | EDJ-KQ17789 | Human | 4311 | Details Get a Quote |
| CPD Knockout A-549 Cell Line | EDJ-KQ22199 | Human | 1362 | Details Get a Quote |
| CPD Knockout HCT 116 Cell Line | EDJ-KQ22200 | Human | 1362 | Details Get a Quote |
| CPD Knockout HeLa Cell Line | EDJ-KQ22201 | Human | 1362 | Details Get a Quote |
| PAM Knockout HeLa Cell Line | EDJ-KQ24895 | Human | 5066 | Details Get a Quote |
Displaying Records 1 To 15 Of 44 Records
- 1
- 2
- Next Page »
Frequently Asked Questions About peptide metabolic process
What is peptide metabolic process GO:0006518?
GO:0006518 is a Gene Ontology term describing the chemical reactions and pathways involving peptides, which are compounds of two or more amino acids linked by peptide bonds.
What genes are involved in peptide metabolic process?
Key genes include GHRL, ANXA1, HLA-A, B2M, TAP1, TAP2, PSMB8, PSMB9, CPE, PCSK1, PCSK2, ACE, DPP4, MME, and SEC11A, among others.
How is peptide metabolic process regulated?
It is regulated by transcriptional control, post-translational modifications such as acylation, and feedback loops involving peptide hormones and their processing enzymes.
What diseases are associated with peptide metabolic process?
Diseases include cerebral ischemia-reperfusion injury, cancer immune evasion, obesity, diabetes, and Alzheimer's disease.
What methods are used to study peptide metabolic process?
Methods include Ribo-seq, RNA-seq, proteomics, peptidomics, live-cell imaging, and CRISPR screening.
How can CRISPR be used to study peptide metabolic process?
CRISPR knockout, point mutation, knock-in, and overexpression models allow precise manipulation of genes involved in peptide metabolism to study their functions.
What is the role of ghrelin in peptide metabolic process?
Ghrelin is a peptide hormone that requires acylation for activity and regulates appetite and metabolic control.
How does peptide metabolism affect the immune system?
Peptides presented by MHC molecules are essential for T cell recognition, and defects in peptide processing can lead to immune evasion in cancer.
What are peptide macrocyclization strategies?
These are chemical approaches to cyclize peptides, enhancing their stability and bioavailability for therapeutic applications.
Why is peptide metabolic process important for drug discovery?
Many drugs are peptides or target peptide-processing enzymes, and understanding their metabolism is crucial for designing effective therapeutics.
Conclusion
Peptide metabolic process (GO:0006518) is a fundamental biological process that governs the synthesis, modification, degradation, and transport of peptides, which play critical roles in signaling, immunity, and metabolism. Dysregulation of this process is linked to a wide range of diseases, including neurological disorders, cancer, and metabolic syndromes. Advances in CRISPR-based models and analytical methods are accelerating our understanding of peptide metabolism and enabling the development of peptide-based therapeutics. EDITGENE's comprehensive CRISPR services provide researchers with the tools needed to dissect these pathways and translate findings into clinical applications.
References
- 1. Zhou H et al.. 2023. Tat-NTS peptide protects neurons against cerebral ischemia-reperfusion injury via ANXA1 SUMOylation in microglia.. Theranostics 13(15):5561-5583 PMID: 37908731
- 2. Ma J et al.. 2025. Dynamic allostery in the peptide/MHC complex enables TCR neoantigen selectivity.. Nat Commun 16(1):849 PMID: 39833157
- 3. Seebach D et al.. 2008. Beta-peptidic peptidomimetics.. Acc Chem Res 41(10):1366-75 PMID: 18578513
- 4. Fang P et al.. 2024. Recent advances in peptide macrocyclization strategies.. Chem Soc Rev 53(24):11725-11771 PMID: 39560122
- 5. Skowicki M et al.. 2024. Nanoassemblies designed for efficient nuclear targeting.. Adv Drug Deliv Rev 211:115354 PMID: 38857762
- 6. Ermert P et al.. 2019. Frontier Between Cyclic Peptides and Macrocycles.. Methods Mol Biol 2001:147-202 PMID: 31134572
- 7. Al Massadi O et al.. 2011. Ghrelin acylation and metabolic control.. Peptides 32(11):2301-8 PMID: 21893140
- 8. Pugliese R et al.. 2017. Peptidic Biomaterials: From Self-Assembling to Regenerative Medicine.. Trends Biotechnol 35(2):145-158 PMID: 27717599
